Lexicon Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Lexicon Pharmaceuticals Inc in one report.
- Save hours of research time and resources with
our up-to-date Lexicon Pharmaceuticals Inc Strategy Report
- Understand Lexicon Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Lexicon Pharmaceuticals Catalyst Calendar
Proactively evaluate Lexicon Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Lexicon Pharmaceuticals Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
31 Dec 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
31 Dec 2019 | Phase III Trial Results | Lexicon Pharmaceuticals Inc; Sanofi | LXRX; SAN | sotagliflozin | Metabolic Disorders | Type 2 Diabetes | Conferences |
01 Dec 2019 | Phase I Trial Completion | Lexicon Pharmaceuticals Inc | LXRX | LX-9211 | Central Nervous System | Neuropathic Pain (Neuralgia) | Company Press Release |
18 Sep 2019 | Phase III Trial Results | Canadian Institutes of Health Research; Center for Women’s Health Research; Colorado Clinical and Translational Sciences Institute; Diabetes Canada; Dutch Diabetes Research Foundation; Faculty of Medicine University of Toronto; International Society for Pediatric and Adolescent Diabetes; Jdrf; Lexicon Pharmaceuticals Inc; National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi; Thrasher Research Fund; U.S. National Institutes of Health; University of Colorado Anschutz Medical Campus | LXRX; SAN | sotagliflozin | Metabolic Disorders | Type 1 Diabetes (Juvenile Diabetes) | Conferences |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer